[Hypoxia and angiogenesis]
- PMID: 17846000
[Hypoxia and angiogenesis]
Abstract
The presence of hypoxic regions within solid tumours is associated with a more malignant tumour phenotype and worse prognosis. To obtain a blood supply and protect against cellular damage and death, oxygen-deprived cells in tumours alter gene expression, resulting in resistance to therapy. Hypoxia is sensed at the cellular level, leading to the activation of molecular pathways to cope with this stress. The key mediator of hypoxia response is HIF1alpha, a member of the hypoxia-inducible factor (HIF) family of proteins. This protein is a transcription factor that stimulates the expression of a multitude of genes important for adaptation to hypoxia, including those encoding angiogenesis. Angiogenesis is stimulated by vascular endothelial growth factor (VEGF), a HIF target gene, to increase blood flow towards oxygen-deprived tissues. This regulation of angiogenesis by hypoxia and HIF is crucial during embryonic development, but also for recovery after ischemic injury. Angiogenesis is one of the physiological responses to hypoxia. Nevertheless, angiogenesis has also deleterious effects by favouring tumour growth.
Similar articles
-
The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.Bull Cancer. 2006 Aug;93(8):E73-80. Bull Cancer. 2006. PMID: 16935775 Review.
-
[The hypoxia-inducible factor HIF as a new target in cancer research].Bull Cancer. 2002 Mar;89(3):257-60. Bull Cancer. 2002. PMID: 11940464 Review. French.
-
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.Integr Cancer Ther. 2005 Dec;4(4):315-21. doi: 10.1177/1534735405282557. Integr Cancer Ther. 2005. PMID: 16282508 Review.
-
Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.Cell Tissue Res. 2003 Oct;314(1):145-55. doi: 10.1007/s00441-003-0763-8. Epub 2003 Jul 29. Cell Tissue Res. 2003. PMID: 12898211 Review.
-
Hypoxia--a key regulatory factor in tumour growth.Nat Rev Cancer. 2002 Jan;2(1):38-47. doi: 10.1038/nrc704. Nat Rev Cancer. 2002. PMID: 11902584 Review.
Cited by
-
Bcl-2 Overexpression and Hypoxia Synergistically Enhance Angiogenic Properties of Dental Pulp Stem Cells.Int J Mol Sci. 2020 Aug 26;21(17):6159. doi: 10.3390/ijms21176159. Int J Mol Sci. 2020. PMID: 32859045 Free PMC article.
-
HIF-1α Promotes A Hypoxia-Independent Cell Migration.Open Biol J. 2010 Jan 1;3:8-14. doi: 10.2174/1874196701003010008. Open Biol J. 2010. PMID: 20882121 Free PMC article.
-
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance.J Exp Clin Cancer Res. 2023 Jul 18;42(1):171. doi: 10.1186/s13046-023-02724-y. J Exp Clin Cancer Res. 2023. PMID: 37460927 Free PMC article. Review.
-
Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.BMC Cancer. 2009 Dec 1;9:418. doi: 10.1186/1471-2407-9-418. BMC Cancer. 2009. PMID: 19948069 Free PMC article.